Furthermore, therapeutic blockade of PD-L1 and TGFβ in an immune-excluded mammary mouse model (EMT6) led to a significant increase in infiltrating T cells as well as tumor regression and suppression of metastasis [293]. The gene discussed is TGFB1; the disease is neoplasm.